INTRODUCTION
Replacement of one or more steroidal carbon atoms with nitrogen or some other heteroatom represents a challenge to synthetic organic chemists (1) (2) (3) . On the other hand, it has been shown that certain steroids with a heteroatom in the carbocyclic moiety possess useful biological properties including anticancer and/or antibacterial activity (4) (5) (6) . Moreover, some 16-oxa analogues of estrane series showed antihypercholesterolemic activity (7) . These facts promted us to synthesize some new D-homo-D-aza estratriene derivatives in order to test subsequently their biological activities.
EXPERIMENTAL
Melting points were determined using a Büchi SMP 20 apparatus and were not corrected. Infrared spectra (ν in cm -1 ) were recorded on a Perkin-Elmer 457 spectrometer. NMR spectra were taken on a Bruker AC 250 E spectrometer operating at 250 MHz (proton) and 62.9 MHz (carbon). Chemical shifts are expressed in parts per million downfield from the tetramethylsylane internal standard. Mass spectra were recorded on a FinniganMath 8230 instrument, using electron impact (70 eV) or chemical ionization (iso-butane) techniques. The organic extracts were dried over anhydrous Na 2 SO 4 , and removal of solvents was carried out under reduced pressure. All reagents used were analytical grade commercially available substances. 
3-Methoxy

3-Methoxy-17-aza-D-homoestra-1,3,5(10)-triene (5)
To a suspension of lithium aluminium hydride (1.0 g, 26.4 mmol) in dry tetrahydrofuran (10 cm 3 ) was added dropwise a solution of compound 2 (1.0 g, 3.2 mmol) in dry tetrahydrofuran (25 cm 3 ). After stirring the mixture at room temperature for 1 h and for additional 2 h at reflux temperature, the MeOH (20 cm 3 ) and water (500 cm 3 ) were added successively. The suspension was extracted with ether, the extract was dried and evaporated. The crude oily product was purified by silica gel column chromatography (100 g; CHCl 3 -MeOH, 9:1) to afford pure 5 (0.64 g, 70%) as a pale yellow oil.
IR ) was stirred at reflux temperature for 3 h. The solution was diluted with water (500 cm 3 ), neutralized with sodium bicarbonate and extracted with ether. The extract was dried and evaporated to an oil. The crude product was purified by silica gel column chromatography (75 g; CHCl 3 -MeOH, 9:1) to afford pure 9 (0.60 g, 73%) as pale yellow oil.
IR 
RESULTS AND DISCUSSION
Two novel D-homo-D-aza estratriene derivatives have been synthesized, applying independent synthetic routes.
As the starting compound in the first route (Scheme 1) we selected 3-methoxyestra-1,3,5(10)-trien-16-oximino-17-one (1) (8), expecting that it will, under appropriate reaction conditions (9) , undergo Beckman rearrangement and afford the corresponding cyclic imide.
Thus, compound 1 was refluxed for 24 h in a mixture of acetic acid and acetic anhydride, using a similar procedure as described earlier (9), whereby two reaction products were formed: 3-methoxy-17-aza-D-homoestra-1,3,5(10)-trien-16,17a-dione (10) (2, 77%), as a product of Beckman rearrangement, and 16-nitrile of the 3-methoxy-16,17-secoestra-1,3,5(10)-trien-16,17-dicarboxylic acid (3, 15%), as a product of Beckmann fragmentation reaction.
The imide 2 was then reduced with lithium aluminium hydride at room temperature in absolute tetrahydrofuran for 3 h. However, according to the IR-spectrum of the isolated product (ν max at 1655 cm -1 ), under the mentioned reaction conditions, only partial reduction occured, yelding the δ-lactam 4 (11) as the only product. The proposed structure of 4 arises from the assumption that reduction of the less hindered 16-carbonyl function is favourable compared to the reduction of the more hindered 17a-carbonyl group.
Therefore, more vigorous reaction conditions of lithium aluminium hydride reduction (1 h at room temperature and 2 h at boiling temperature of tetrahydrofurane solution) have been applied, affording 3-methoxy-17-aza-D-homoestra-1,3,5(10)-triene (5) in a 70% yield. The starting compound for the second pathway was 3-methoxy-17-oxo-16,17-secoestra-1,3,5(10)-trien-16-nitrile (6; Scheme 2), obtained from 3-methoxy-17β-hydroxyestra-1,3,5(10)-trien-16-oxime by the conventional procedure (8) . In order to protect the aldehyde function, compound 6 was converted to the ethylene acetal 7, applying the previously described procedure (12) . Reduction of the nitrile function to 7 was achieved by the action of sodium borohydride in the presence of cobalt chloride, whereby the oily 3-methoxy-17,17-ethylendioxy-16,17-secoestra-1,3,5(10)-trien-16-amine (8) Finally, the crude amino-acetal 8 was treated with diluted hydrochloric acid under reflux for 3 h. The mixture was then neutralized, the reaction product 9 was extracted with ether and purified by column chromatography. The formation of 3-methoxy-17-aza-D-homoestra-1,3,5(10),17(17a)-tetraene (9) from 8 can be explained by the hydrolysis of its acetal function, subsequently followed by intramolecular Shiff's base formation.
CONCLUSION
This work was concerned with the two syntheses of D-homo-D-aza estratriene derivatives. 3-Methoxy-17-aza-D-homoestra-1,3,5(10)-triene (5) was obtained from 3-methoxyestra-1,3,5(10)-trien-16-oximino-17-one (1) through a two-step sequence. 3-Methoxy-17-aza-D-homoestra-1,3,5(10),17(17a)-tetraene (9) was obtained from 3-methoxy-17-oxo-16,17-secoestra-1,3,5(10)-trien-16-nitrile (6) by a three-step sequence.
